Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Medicine

• Publication date

  2012-01-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2613PMID 22286308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations

  2012cited by this paper
• Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy

  2011cited by this paper
• Tau protein: relevance to Parkinson's disease.

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

  2010cited by this paper
• Genetic analysis of MAPT haplotype diversity in frontotemporal dementia.

  2008cited by this paper
• Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia

  2008cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Individual dopaminergic neurons show raised iron levels in Parkinson disease

  2007cited by this paper
• Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease

  2007cited by this paper
• Mechanisms and Models

  2007cited by this paper
• Multifunctional Activities of Green Tea Catechins in Neuroprotection

  2005cited by this paper
• Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

  2005cited by this paper
• The biochemistry of Parkinson's disease.

  2005cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study

  2003cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease

  2002cited by this paper
• The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety

  2001cited by this paper
• Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

  2001cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Behavioral phenotyping of the MPTP mouse model of Parkinson's disease.

  2001cited by this paper
• Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice.

  2000cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

  1999cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease

  1995cited by this paper
• Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains

  1994cited by this paper
• Altered microtubule organization in small-calibre axons of mice lacking tau protein

  1994cited by this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

  1992cited by this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.

  1992cited by this paper
• Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1.

  1988cited by this paper
• [Biochemistry of Parkinson's disease].

  1988cited by this paper

• Targeting the Gut-Brain-Ferroptosis Axis: Molecular Mechanisms and Therapeutic Potential in Alzheimer’s Disease and Epilepsy

  2026cites this paper
• Ferroptosis and Alzheimer's disease: a new insight into neurodegeneration.

  2026cites this paper
• Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

  2026cites this paper
• Diagnosis of Cognitive Impairment in Chronic Kidney Disease: A Radiomics and Machine Learning Approach with Quantitative Susceptibility Mapping.

  2026cites this paper
• Ferroptosis in neurological diseases: moving towards therapeutic intervention.

  2026cites this paper
• Reexamining the Role of Amyloid β Clearance from the Brain: Exporting Labile Iron from the Interstitial Fluid Performs a Protective Function

  2026cites this paper
• Epothilone B stabilizes microtubules via Tau to protect retinal ganglion cells and promote axon regeneration.

  2026cites this paper
• Iron on trial: recasting the role of iron in neurodegeneration.

  2025cites this paper
• Neuroferroptosis in health and diseases

  2025cites this paper
• Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update

  2025cites this paper
• Combinatorial mechanisms specify cellular location and neurotransmitter identity during regeneration of planarian neurons

  2025cites this paper
• Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)

  2025cites this paper
• Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

  2025cites this paper
• Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.

  2025cites this paper
• Alterations in iron levels in the locus coeruleus of a transgenic Alzheimer’s disease rat model

  2025cites this paper
• Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

  2025cites this paper
• Evidence of COMT dysfunction in the olfactory bulb in Parkinson’s disease

  2025cites this paper
• Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer’s Disease

  2025cites this paper
• The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights.

  2025cites this paper
• Quantitative magnetic resonance imaging in Alzheimer’s disease: a narrative review

  2025influential citation
• Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells.

  2025cites this paper
• Diverse influences on tau aggregation and implications for disease progression

  2025cites this paper
• Herbacetin alleviates Parkinson's disease by inhibiting ferroptosis in PC12 cells through the Nrf2/GPX4 pathway.

  2025cites this paper
• Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson’s disease

  2025cites this paper
• The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

  2025cites this paper
• Role of iron in brain development, aging, and neurodegenerative diseases

  2025cites this paper
• Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders.

  2025cites this paper
• Triggering ferroptosis in neurodegenerative diseases.

  2025cites this paper
• Systematic Review and Meta-Analysis on Heavy Metals and Trace Elements in Mild Cognitive Impairment.

  2025cites this paper
• Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy

  2025cites this paper
• In defence of ferroptosis

  2025cites this paper
• The impact of tau deletion on Huntington's disease: an in vivo perspective.

  2025cites this paper
• Crosstalk between copper, Alzheimer’s disease, and melatonin

  2025cites this paper
• Driving factors of neuronal ferroptosis.

  2024cites this paper
• Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke

  2024cites this paper
• Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

  2024cites this paper
• P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.

  2024cites this paper
• The potential roles of salivary biomarkers in neurodegenerative diseases.

  2024cites this paper
• Cellular and pathological functions of tau

  2024cites this paper
• Global Research Trends and Hotspots for Ferroptosis, Necroptosis, and Pyroptosis in Alzheimer’s Disease from the Past to 2023: A Combined Bibliometric Review

  2024cites this paper
• Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer's disease and related tauopathies.

  2024cites this paper
• Pros and cons of narrow- versus wide-compartment rotarod apparatus: an experimental study in mice.

  2024cites this paper
• Passive immunotherapy for Alzheimer's disease.

  2024cites this paper
• Amyotrophic lateral sclerosis associated disturbance of iron metabolism is blunted by swim training-role of AKT signaling pathway.

  2024cites this paper
• Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease

  2024cites this paper
• Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy

  2024cites this paper
• DNALI1 Promotes Neurodegeneration after Traumatic Brain Injury via Inhibition of Autophagosome‐Lysosome Fusion

  2024cites this paper
• A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4

  2024cites this paper
• The role of ferritinophagy and ferroptosis in Alzheimer's disease.

  2024cites this paper
• Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes

  2024cites this paper
• The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.

  2024cites this paper
• Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment

  2024cites this paper
• The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review

  2024cites this paper
• Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

  2024cites this paper
• Targeting Metals in Alzheimer’s Disease: An Update

  2024cites this paper
• Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress

  2024cites this paper
• Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review

  2024cites this paper
• Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets.

  2024cites this paper
• Retinal hyperspectral imaging in mouse models of Parkinson’s disease and healthy aging

  2024influential citation
• Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms

  2024cites this paper
• Animal models of Alzheimer’s disease: Current strategies and new directions

  2024cites this paper
• Cell density impacts the susceptibility to ferroptosis by modulating IRP1‐mediated iron homeostasis

  2024cites this paper
• Ferroptosis in ischemic stroke: Animal models and mechanisms

  2024cites this paper
• Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery

  2024cites this paper
• Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer’s Disease Pathophysiology: Two Faces of the Same Coin

  2024cites this paper
• Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype

  2024cites this paper
• Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview

  2024cites this paper
• Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

  2024cites this paper
• Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD)

  2024cites this paper
• Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases

  2024cites this paper
• The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases

  2024influential citation
• Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthood

  2024cites this paper
• Ferroptosis in health and disease

  2024cites this paper
• Ferroptosis: A New Strategy for Targeting Alzheimer's Disease.

  2024cites this paper
• Whole-exome sequencing identifies protein-coding variants associated with brain iron in 29,828 individuals

  2024cites this paper
• Association of triglyceride-glucose index and delirium in patients with sepsis: a retrospective study

  2024cites this paper
• Towards early detection of neurodegenerative diseases: A gut feeling

  2023influential citation
• Perturbed iron biology in the prefrontal cortex of people with schizophrenia

  2023cites this paper
• The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis

  2023cites this paper
• Transgenic Mouse Models for the Study of Neurodegenerative Diseases.

  2023cites this paper
• Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease

  2023cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism

  2023cites this paper
• Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease

  2023cites this paper
• Triglyceride-glucose index as a valuable predictor for aged 65-years and above in critical delirium patients: evidence from a multi-center study

  2023cites this paper
• Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis

  2023cites this paper
• Tau reduction attenuates autism-like features in Fmr1 knockout mice

  2023cites this paper
• Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease

  2023cites this paper
• Tau suppresses microtubule-regulated pancreatic insulin secretion

  2023cites this paper
• TRIMming the tangles.

  2023cites this paper
• Literature-based predictions of Mendelian disease therapies.

  2023cites this paper
• Research Progress in the Molecular Mechanism of Ferroptosis in Parkinson's Disease and Regulation by Natural Plant Products.

  2023cites this paper
• NRF2, a Superstar of Ferroptosis

  2023cites this paper
• Diagnostic and therapeutic targeting of pathological tau proteins in neurodegenerative disorders

  2023cites this paper
• Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects.

  2023cites this paper
• Ferroptosis and endoplasmic reticulum stress in ischemic stroke

  2023cites this paper
• Alzheimer's disease and related tauopathies: disorders of disrupted neuronal identity.

  2023cites this paper
• Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease.

  2023cites this paper